» Articles » PMID: 38672721

Ablative Treatments for Small Renal Masses and Management of Recurrences: A Comprehensive Review

Abstract

This review focuses on ablative techniques for small renal masses (SRMs), including radiofrequency ablation (RFA), cryoablation (CA), microwave ablation (MWA), and irreversible electroporation (IRE), and discusses recurrence management. Through an extensive literature review, we outline the procedures, outcomes, and follow-up strategies associated with each ablative method. The review provides a detailed examination of these techniques-RFA, CA, MWA, and IRE-elucidating their respective outcomes. Recurrence rates vary among them, with RFA and CA showing comparable rates, MWA demonstrating favorable short-term results, and IRE exhibiting promise in experimental stages. For managing recurrences, various strategies are considered, including active surveillance, re-ablation, or salvage surgery. Surveillance is preferred post-RFA and post-CA, due to slow SRM growth, while re-ablation, particularly with RFA and CA, is deemed feasible without additional complications. Salvage surgery emerges as a viable option for larger or resistant tumors. While ablative techniques offer short-term results comparable to surgery, further research is essential to understand their long-term effects fully. Decisions concerning recurrence management should consider individual and tumor-specific factors. Imaging, notably contrast-enhanced ultrasounds, plays a pivotal role in assessing treatment success, emphasizing the necessity of a multidisciplinary approach for optimal outcomes. The lack of randomized trials highlights the need for further research.

Citing Articles

Determinants of conventional and contrast-enhanced ultrasound diagnosis of fat-poor angiomyolipoma <5 cm.

Liang X, Zeng X, Hong Z, Su M, Yang J, Wu S Front Oncol. 2024; 14:1446801.

PMID: 39735609 PMC: 11671361. DOI: 10.3389/fonc.2024.1446801.


Application of cryoablation in animal models of bladder and muscle-invasive bladder cancer: a narrative review of current status and future perspectives.

Wang Y, Li X Quant Imaging Med Surg. 2024; 14(12):9653-9666.

PMID: 39698593 PMC: 11652053. DOI: 10.21037/qims-24-1174.


Robot-assisted partial nephrectomy vs. percutaneous cryoablation for T1a renal tumors: a single-center retrospective analysis of outcomes and costs.

Iossa V, Pandolfo S, Buonopane R, Di Girolamo A, Fiore F, Sessa G Int Urol Nephrol. 2024; 57(4):1097-1104.

PMID: 39576419 DOI: 10.1007/s11255-024-04238-8.


High-frequency irreversible electroporation ablation for the prostate in Beagle dogs.

Xing R, Ji S, Li X, Gong T, Jiang Q Transl Androl Urol. 2024; 13(9):2016-2026.

PMID: 39434756 PMC: 11491217. DOI: 10.21037/tau-24-108.


Perioperative and Oncological Outcomes of Percutaneous Radiofrequency Ablation versus Partial Nephrectomy for cT1a Renal Cancers: A Retrospective Study on Groups with Similar Clinical Characteristics.

Jasinski M, Wisniewski P, Bielinska M, Siekiera J, Kamecki K, Salagierski M Cancers (Basel). 2024; 16(8).

PMID: 38672611 PMC: 11049424. DOI: 10.3390/cancers16081528.

References
1.
Neves J, Cullen D, Grant L, Walkden M, Bandula S, Patki P . Protocol for a feasibility study of a cohort embedded randomised controlled trial comparing phron paring reatment (NEST) for small renal masses. BMJ Open. 2019; 9(6):e030965. PMC: 6577353. DOI: 10.1136/bmjopen-2019-030965. View

2.
Maccini M, Sehrt D, Pompeo A, Chicoli F, Molina W, Kim F . Biophysiologic considerations in cryoablation: a practical mechanistic molecular review. Int Braz J Urol. 2012; 37(6):693-6. DOI: 10.1590/s1677-55382011000600002. View

3.
De Vita E, Presti D, Massaroni C, Iadicicco A, Schena E, Campopiano S . A review on radiofrequency, laser, and microwave ablations and their thermal monitoring through fiber Bragg gratings. iScience. 2023; 26(11):108260. PMC: 10660479. DOI: 10.1016/j.isci.2023.108260. View

4.
Pierorazio P, Johnson M, Patel H, Sozio S, Sharma R, Iyoha E . Management of Renal Masses and Localized Renal Cancer: Systematic Review and Meta-Analysis. J Urol. 2016; 196(4):989-99. PMC: 5593254. DOI: 10.1016/j.juro.2016.04.081. View

5.
Pandolfo S, Loizzo D, Beksac A, Derweesh I, Celia A, Bianchi L . Percutaneous thermal ablation for cT1 renal mass in solitary kidney: A multicenter trifecta comparative analysis versus robot-assisted partial nephrectomy. Eur J Surg Oncol. 2022; 49(2):486-490. DOI: 10.1016/j.ejso.2022.09.022. View